Bank Of America Corp Sio Gene Therapies Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.28 - $0.44 $36 - $57	130 Added 114.04%	244 $0
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $2,088 - $6,096	-8,352 Reduced 98.65%	114 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $1.47 $7,101 - $18,979	-12,911 Reduced 60.4%	8,466 $6,000
Q4 2021 Feb 08, 2022	BUY	$1.29 - $2.36 $153 - $280	119 Added 0.56%	21,377 $27,000
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $38,440 - $57,342	21,238 Added 106190.0%	21,258 $46,000
Q2 2021 Sep 13, 2021	BUY	$2.07 - $2.89 $41 - $57	20 New	20 $0

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.